Status In progress
Process STA 2018
ID number 1124

Provisional Schedule

Committee meeting: 2 16 July 2019
Expected publication 31 July 2019

Project Team

Project lead Thomas Feist

Email enquiries

Evidence Review Group / Assessment Group School of Health and Related Research (ScHARR), University of Sheffield

Consultees

Companies sponsors AstraZeneca
Others Department of Health
  NHS England
  Welsh Government
Patient carer groups Ovarian Cancer Action
  Target Ovarian Cancer
  Ovacome
Professional groups Association of Cancer Physicians
  British Gynaecological Cancer Society
  Cancer Research UK
  Royal College of Physicians
  Royal College of Radiologists

Commentators

General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health and Social Services and Public Safety, Northern Ireland
  Healthcare Improvement Scotland
  Scottish Medicines Consortium
  Welsh Health Specialised Services Committee
Relevant research groups National Cancer Research Institute

Timeline

Key events during the development of the guidance:

Date Update
16 May 2019 Committee meeting: 1
19 September 2018 Invitation to participate
29 September 2017 In progress, In progress

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance